134 related articles for article (PubMed ID: 37639839)
1. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
[TBL] [Abstract][Full Text] [Related]
2. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphoma of the gastrointestinal tract: A rare entity with a dismal prognosis.
Komaranchath AS; Haleshappa RA; Kuntegowdenahalli LC; Kumar RV; Dasappa L; Babu G
Indian J Cancer; 2016; 53(4):529-533. PubMed ID: 28485344
[TBL] [Abstract][Full Text] [Related]
5. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.
Fukuo Y; Shibuya T; Ashizawa K; Ito K; Saeki M; Fukushima H; Takahashi M; Nomura K; Okahara K; Haga K; Akazawa Y; Nomura O; Ogura K; Okubo H; Nagahara A
Intern Med; 2021 Sep; 60(18):2947-2952. PubMed ID: 33776007
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
[TBL] [Abstract][Full Text] [Related]
8. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
9. Plasmablastic lymphoma: An update.
Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
[TBL] [Abstract][Full Text] [Related]
10. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy.
Ogiyama H; Murayama Y; Tsutsui S; Iwasaki T; Kuriyama D; Horiki M; Imanaka K; Kimura H; Inoue M; Iishi H
Clin J Gastroenterol; 2023 Apr; 16(2):198-205. PubMed ID: 36609818
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal Tract Plasmablastic Lymphoma in HIV-Infected Adults: A Histopathological Review.
Mwazha A; Nhlonzi GB; Mazengenya P
Int J Surg Pathol; 2020 Oct; 28(7):735-748. PubMed ID: 32552168
[TBL] [Abstract][Full Text] [Related]
12. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
[TBL] [Abstract][Full Text] [Related]
13. From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.
Gietzen R; Muthukumarana V; Bhargava P; Vozniuk D; Thakral B; Medeiros LJ; Lyapichev KA
Ann Diagn Pathol; 2023 Dec; 67():152186. PubMed ID: 37541853
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
[TBL] [Abstract][Full Text] [Related]
15. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male.
Shwe S; Sharma AA; Lee BA; Smith JE
Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
[TBL] [Abstract][Full Text] [Related]
18. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
[TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of plasmablastic lymphoma in immunocompetent patient.
Khan MD; Natarajan S; Lekharaju V
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848405
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea.
Kim JE; Kim YA; Kim WY; Kim CW; Ko YH; Lee GK; Choi SJ; Jeon YK
Leuk Lymphoma; 2009 Apr; 50(4):582-7. PubMed ID: 19373656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
